Fertility test kits are diagnostic products used to check fertility levels and monitor ovulation in women. Fertility test kits help determine the fertile days when conception is most likely to occur. They are used at home with urine or blood samples and provide fast results, which make them more convenient compared to lab tests. The growing cases of infertility due to lifestyle changes, rising age of parenthood, and increasing risk of pregnancy complications are driving the demand for fertility test kits.

The global Fertility Test Market is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

Rising infertility rates around the world present a major market opportunity for fertility test kit manufacturers. infertility rates have been consistently rising over the past few decades owing to lifestyle changes, stress, obesity, and other factors. According to the World Health Organization, around 48 million couples worldwide suffer from infertility. To address this growing problem, assisted reproductive technology along with ovulation and fertility monitoring solutions like fertility test kits are increasingly being relied upon. The overall demand for fertility test kits is expected to rise significantly owing to growing cases of infertility. Manufacturers can capitalize on this opportunity by developing advanced and accurate home use fertility test kits that can help couples plan conception and seek medical help timely.

Porter's Analysis

Threat of new entrants: The threat of new entrants is low as the Global fertility test market size requires high R&D investments and established distribution networks.

Bargaining power of buyers: The bargaining power of buyers is high given the availability of substitute products and undifferentiated nature of products.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw materials required are commonly available.

Threat of new substitutes: The threat of new substitutes is moderate as new testing technologies can emerge as substitutes.

Competitive rivalry: The competitive rivalry is high among existing players to gain market share.

SWOT Analysis

Strength: Existing players have strong distribution networks and brand recognition. home based tests provide convenient testing options.

Weakness: Accuracy of home based tests is still a concern. Lack of medical supervision can cause errors in self-testing. Cost of fertility clinic tests is relatively high.

Opportunity: Increasing fertility problems due to changing lifestyle presents an opportunity. Growing awareness about early diagnosis and treatment is driving the market.

Threats: Stringent regulations for approval of new products increases cost and compliance burden for players. Social stigma and privacy concerns impacts adoption of fertility tests.

Key Takeaways

The global fertility test market is expected to witness high growth aided by the rising cases of infertility worldwide.

Regional Analysis: The Asia Pacific region dominates the market and is expected to grow the fastest during the forecast period due to the large population, growing healthcare expenditure, and increasing public awareness about fertility and conception.

Key players operating in the fertility test market are AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., and Boehringer Ingelheim International GmbH. AstraZeneca manufactures oral contraceptives such as Minocin while Novartis’s fertility drugs include Luveris.

Get More Insights On This Topic: https://www.newswirestats.com/fertility-tests-market-forecast-outlook-trend-2023-2030/

Explore More Trending Article On This Topic: https://filmik.in/cracking-the-code-of-epigenetics-the-harmony-of-gene-expression-outside-of-dna/